DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Disclosure under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 201527-03-2024
27-03-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share Certificates26-03-2024
Dr Reddy's Inks Licensing Pact With U.S. Firm To Commercialise Centhaquine In India
Developed by Pharmazz, Centhaquine is a resuscitative agent indicated for the treatment of hypovolemic shock by the Drugs Controller General of India (DCGI).22-03-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Closure of Trading Window
The trading window for dealing in the securities of the Company will be closed from March 25, 2024 to May 9, 2024 (both days inclusive)22-03-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Board Meeting Intimation for Board Meeting Intimation For Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ending On March 31, 2024, And To Recommend Dividend, If Any, For The Financial Year 2023-24.
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2024 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ending on March 31, 2024, and to recommend dividend, If any, for the financial year 2023-24.22-03-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement Under Regulation 30 Of SEBI LODR Regulations
Press Release22-03-2024
Dr Reddy's Launches Cancer Treatment Drug Versavo In U.K.
Dr Reddy's Laboratories has launched its cancer treatment drug Versavo in the United Kingdom.19-03-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share certificate(s)15-03-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of equity shares under ESOP schemes of the Company15-03-2024